{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:57Z","timestamp":1707524937040},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,5]]},"DOI":"10.7759\/cureus.34654","type":"journal-article","created":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T23:29:36Z","timestamp":1675639776000},"source":"Crossref","is-referenced-by-count":0,"title":["A Possible Case of Nitrofurantoin-Associated Immune Thrombocytopenia in a Healthy 45-Year-Old Caucasian Female"],"prefix":"10.7759","author":[{"given":"Caleb","family":"Ramey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"LePera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero F","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, et al.. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009, 113:2386-93. 10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03360.x","article-title":"Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"Aster RH","year":"2009","unstructured":"Aster RH, Curtis BR, McFarland JG, Bougie DW. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009, 7:911-8. 10.1111\/j.1538-7836.2009.03360.x","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2005.tb01887.x","article-title":"Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease","volume":"94","author":"Zeller B","year":"2005","unstructured":"Zeller B, Rajantie J, Hedlund-Treutiger I, et al.. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr. 2005, 94:178-84. 10.1111\/j.1651-2227.2005.tb01887.x","journal-title":"Acta Paediatr"},{"key":"ref4","unstructured":"Immune thrombocytopenia. NORD (National Organization for Rare Disorders). (2022). Accessed. November 1, 2022: https:\/\/rarediseases.org\/rare-diseases\/immune-thrombocytopenia\/."},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.21307\/immunohematology-2019-099","article-title":"Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms","volume":"30","author":"Curtis BR","year":"2014","unstructured":"Curtis BR. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms. Immunohematology. 2014, 30:55-65.","journal-title":"Immunohematology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-044388","article-title":"Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura","volume":"109","author":"Sukati H","year":"2007","unstructured":"Sukati H, Watson HG, Urbaniak SJ, Barker RN. Mapping helper T-cell epitopes on platelet membrane glycoprotein IIIa in chronic autoimmune thrombocytopenic purpura. Blood. 2007, 109:4528-38. 10.1182\/blood-2006-09-044388","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03161.x","article-title":"Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura","volume":"7","author":"Kuwana M","year":"2009","unstructured":"Kuwana M, Okazaki Y, Ikeda Y. Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura. J Thromb Haemost. 2009, 7:322-9. 10.1111\/j.1538-7836.2008.03161.x","journal-title":"J Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan D","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, et al.. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019, 3:3780-817. 10.1182\/bloodadvances.2019000812","journal-title":"Blood Adv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25379","article-title":"Drug-induced thrombocytopenia: 2019 update of clinical and laboratory data","volume":"94","author":"Mitta A","year":"2019","unstructured":"Mitta A, Curtis BR, Reese JA, George JN. Drug-induced thrombocytopenia: 2019 update of clinical and laboratory data. Am J Hematol. 2019, 94:E76-8. 10.1002\/ajh.25379","journal-title":"Am J Hematol"},{"key":"ref10","unstructured":"Drug-induced thrombocytopenia. (2015). Accessed. November 1, 2022: https:\/\/ouhsc.edu\/platelets\/ditp.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2018.1468025","article-title":"Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature","volume":"29","author":"Alzahrani M","year":"2018","unstructured":"Alzahrani M, Alrumaih I, Alhamad F, Abdel Warith A. Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature. Platelets. 2018, 29:628-31. 10.1080\/09537104.2018.1468025","journal-title":"Platelets"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-181073","article-title":"Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia","volume":"113","author":"Zhang W","year":"2009","unstructured":"Zhang W, Nardi MA, Borkowsky W, Li Z, Karpatkin S. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood. 2009, 113:4086-93. 10.1182\/blood-2008-09-181073","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07714.x","article-title":"Cytomegalovirus can make immune thrombocytopenic purpura refractory","volume":"146","author":"DiMaggio D","year":"2009","unstructured":"DiMaggio D, Anderson A, Bussel JB. Cytomegalovirus can make immune thrombocytopenic purpura refractory. Br J Haematol. 2009, 146:104-12. 10.1111\/j.1365-2141.2009.07714.x","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.12.005","article-title":"Pathobiology of secondary immune thrombocytopenia","volume":"46","author":"Cines DB","year":"2009","unstructured":"Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009, 46:S2-14. 10.1053\/j.seminhematol.2008.12.005","journal-title":"Semin Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari G","year":"2013","unstructured":"Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013, 27:495-520. 10.1016\/j.hoc.2013.03.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.153","article-title":"Drug-induced thrombocytopenia: pathogenesis, evaluation, and management","volume":"2009","author":"George JN","year":"2009","unstructured":"George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009, 2009:153-8. 10.1182\/asheducation-2009.1.153","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-006507","article-title":"Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus","volume":"2012","author":"L\u00f3pez-L\u00f3pez L","year":"2012","unstructured":"L\u00f3pez-L\u00f3pez L, Rivera-Rodr\u00edguez N, Vil\u00e1 LM. Nitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus. BMJ Case Rep. 2012, 2012:bcr2012006507. 10.1136\/bcr-2012-006507","journal-title":"BMJ Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0066","article-title":"Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study","volume":"17","author":"Ioachimescu AG","year":"2007","unstructured":"Ioachimescu AG, Makdissi A, Lichtin A, Zimmerman RS. Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study. Thyroid. 2007, 17:1137-42. 10.1089\/thy.2007.0066","journal-title":"Thyroid"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.05.006","article-title":"Prescription medication use and antinuclear antibodies in the United States, 1999-2004","volume":"92","author":"Dinse GE","year":"2018","unstructured":"Dinse GE, Parks CG, Meier HC, et al.. Prescription medication use and antinuclear antibodies in the United States, 1999-2004. J Autoimmun. 2018, 92:93-103. 10.1016\/j.jaut.2018.05.006","journal-title":"J Autoimmun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.24966\/HBTD-2999\/100015","article-title":"The effect of anti-nuclear antibody positivity on immune thrombocytopenic purpura and its clinical course","volume":"4","author":"Ezzat LA","year":"2017","unstructured":"Ezzat LA, Ezzat HM. The effect of anti-nuclear antibody positivity on immune thrombocytopenic purpura and its clinical course. J Hematol Blood Transfus Disord. 2017, 4:1-3. 10.24966\/HBTD-2999\/100015","journal-title":"J Hematol Blood Transfus Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/134584-a-possible-case-of-nitrofurantoin-associated-immune-thrombocytopenia-in-a-healthy-45-year-old-caucasian-female","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:34Z","timestamp":1707508174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/134584-a-possible-case-of-nitrofurantoin-associated-immune-thrombocytopenia-in-a-healthy-45-year-old-caucasian-female"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.34654","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,5]]}}}